click below
click below
Normal Size Small Size show me how
Pharm6
Pharmacology 6
| Question | Answer |
|---|---|
| osteoporosis | a condition in which the patient experiences reduced bone mineral density, disrupted microarchitecture of bone structure, and increased likelihood of fracture |
| arthritis | disorder characterized by persistent pain due to functional problems of the joints |
| disease-modifying antirheumatic drugs | agents that can potentially modify the progression of rheumatoid arthritis |
| osteoarthritis | a degenerative joint disease resulting in loss of cartilage, cartilage elasticity, and bone thickness |
| acupuncture | a process that involves penetrating |
| hip fracture | a break in the upper quarter of the femur (thigh) bone often caused by osteoporosis |
| striated | striped |
| bone remodeling | the continual process of bone buildup and breakdown to maintain mineral balance in the body |
| inflammation | the body’s response to tissue injury or infection, commonly including heat, redness, and swelling |
| cyclooxygenase-2 | an enzyme that is associated with the pain and inflammation of arthritis |
| muscle | an organ that produces movement by contracting (shortening itself) |
| nonsteroidal anti-inflammatory drugs | a class of drugs that provides reduction of pain, swelling, inflammation, and fever |
| gouty arthritis | a disease resulting from the improper excretion of uric acid; also called gout |
| osteoblast | a cell that takes calcium from the blood and uses it to build bone tissue |
| concomitant | accompanying |
| analgesic | a medication that reduces pain |
| acetylcholine (ACh) | a neurotransmitter that binds |
| antipyretic | fever reducing |
| muscle relaxant | a drug that provides skeletal muscle relaxation or relief from muscle spasms, as well as pain relief |
| rheumatoid arthritis | an autoimmune disorder in which the immune system destroys the synovial membrane of the joint, |
| cyclooxygenase-1 | an enzyme that promotes the production of prostglandins and causes pain and inflammation; also produces |
| tophus | a deposit of sodium urate around a joint, which is a symptom of gout |
| T-score | the result of a bone mineral density screening, which helps determine a patient’s risk of osteoporosis |
| osteoclast | a cell that breaks down bone and releases calcium into the bloodstream |
| muscle spasm | an involuntary contraction of muscle fibers; also called a cramp |
| cardiac muscle | heart muscle; responsible for the involuntary contraction of the heart |
| skeletal muscle | striated muscle in which contraction is voluntary, or under direct control; also known as voluntary muscle |
| salicylates | a class of nonnarcotic analgesics that have pain-relieving, antipyretic (feverreducing), and anti-inflammatory properties |
| biologic response modifiers | drugs that target the part of the immune system responsible for inflammation and joint damage |
| selective estrogen receptor modulators | drugs for treating osteoporosis that work as estrogen receptors by mimicking the beneficial effects of estrogen on bone mineral density |
| joint | place of union or junction between two or more bones of the skeleton |
| bone mineral density | the amount of mineral content for a particular volume of bone; can help indicate a patient's risk of |
| smooth muscle | muscle in which contraction is involuntary; often found in organs (such as the stomach); also known as involuntary muscle |
| hyperpnea | abnormal increase in the depth of breathing |